TB or not TB: Total Synthesis of Transvalencin Z

  • Author: David Bradley
  • Published: 25 May 2012
  • Copyright: Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
  • Source / Publisher: Journal of Natural Products/ACS Publications
thumbnail image: TB or not TB: Total Synthesis of Transvalencin Z

The pulmonary infection tuberculosis (TB), popularly thought of as a disease of a bygone era, and once known as "consumption", is very much on the rise with a global epidemic of drug-resistant strains threatening our health today. Latent, asymptomatic TB is endemic and as a co-infection with HIV an increasingly worrying health issue particularly in the developing world. Antibiotics used against TB were developed more than four decades ago.


Chemists at the University of Minnesota, USA, have now developed a useful total synthesis of transvalencin Z (pictured), originally derived from the fungi-like bacterium Nocardia transvalensis. The compound is relatively potent and selective against Mycobacterium smegmatis, which the team says makes it an attractive target for structure–activity studies in research to treat the related species M. tuberculosis; its mode of action should be very different from those old antibiotics. Its absolute configuration has also been defined using the synthesis, chromatographic retention times, and optical rotation experiments.


Article Views: 1972

Sign in Area

Please sign in below

Additional Sign In options

Please note that to comment on an article you must be registered and logged in.
Registration is for free, you may already be registered to receive, e.g., the newsletter. When you register on this website, please ensure you view our terms and conditions. All comments are subject to moderation.

Article Comments - To add a comment please sign in

1 Comments

Srinivasa Dandepally wrote:

Synthetic Transvalencin Z failed to show any potency

Based on the paper reported by Aldrich and coworkers, the synthetic Transvalencin Z and other 3 diasteromers failed to exhibit any inhibitory activity against a panel of microbial pathogens, including several species of mycobacteria. Any way, it's a great effort by Aldrich for disclosing the synthesis and biological studies of synthetic molecules.

Thu May 31 14:19:15 UTC 2012

Bookmark and Share

If you would like to reuse any content, in print or online, from ChemistryViews.org, please contact us first for permission. more


CONNECT:

ChemistryViews.org on Facebook

ChemistryViews.org on Twitter ChemistryViews.org on YouTube ChemistryViews.org on LinkedIn Sign up for our free newsletter


A product of ChemPubSoc Europe (16 European Chemical Societies)and Wiley-VCH